Chantal Mathieu: Celebrating International Women’s Day 2022
It was an honour to speak to valued editorial board member Professor Chantal Mathieu (Katholieke Universiteit Leuven, Belgium) who shared her experiences of building her career and becoming an international thought leader in diabetes, whilst also bringing up her son and being present in her personal life.
Questions
- Why is International Women’s Day so important? 00:22-00:51
- What have been the major highlights and challenges in your career? 00:51-04:58
Speaker Disclosure: Chantal Mathieu serves or has served on the advisory panel for: Novo Nordisk, Sanofi, Merck Sharp and Dohme Ltd., Eli Lilly and Company, Novartis, AstraZeneca, Boehringer Ingelheim, Roche, Medtronic, ActoBio Therapeutics, Pfizer, Imcyse, Insulet and Zealand Pharma. Financial compensation for these activities has been received by: KU Leuven; KU Leuven has received research support for Chantal Mathieu from: Medtronic, Imcyse, Novo Nordisk, Sanofi and ActoBio Therapeutics; Chantal Mathieu serves or has served on the speakers bureau for Novo Nordisk, Sanofi, Eli Lilly and Company, Boehringer Ingelheim, Astra Zeneca and Novartis. Financial compensation for these activities has been received by KU Leuven.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of International Women’s Day 2022.
